BLM and cancer: In human, there are five RecQ homologs, and deficiencies in three of them, BLM/RecQ2, WRN/RecQ3 and RTS/RecQ4, give rise, respectively, to Bloom6, Werner7 and Rothmund-Thomson8 syndromes that are characterized by genomic instability and cancer predisposition4.